Cargando…
Differences in ICU Outcomes According to the Type of Anticancer Drug in Lung Cancer Patients
PURPOSE: We investigated the intensive care unit (ICU) outcomes of patients who used targeted therapy compared to those who received cytotoxic chemotherapy. MATERIALS AND METHODS: This study was based on Korean administrative health insurance claims from 2015 to 2019. We extracted data on lung cance...
Autores principales: | Hong, Yoonki, Hong, Ji Young, Park, Jinkyeong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882653/ https://www.ncbi.nlm.nih.gov/pubmed/35237632 http://dx.doi.org/10.3389/fmed.2022.824266 |
Ejemplares similares
-
Risk for multidrug-resistant tuberculosis in patients treated with anti-tumor necrosis factor agents
por: Park, Jinkyeong, et al.
Publicado: (2023) -
Clinical outcomes in patients with lung cancer admitted to intensive care units
por: Park, Jinkyeong, et al.
Publicado: (2021) -
Gender Differences in Antitussive Prescriptions for Chronic Cough in Korea
por: Park, Jinkyeong, et al.
Publicado: (2023) -
The Role of Transbronchial Lung Biopsy in Diagnosing Pulmonary Mucormycosis in a Critical Care Unit
por: Hong, Yoonki, et al.
Publicado: (2017) -
A Comprehensive Analysis of 5-Year Outcomes in Patients with Cancer Admitted to Intensive Care Units
por: Hong, Yoonki, et al.
Publicado: (2022)